There is a particular silence around male infertility that is different from the silence around infertility in general.

Infertility, as a subject, has gradually found more voice in Indian society — more awareness, more openness in some communities, more willingness to acknowledge that it exists and that it is a medical condition rather than a personal failing. This change is incomplete and uneven, but it is real.

Male infertility, however, remains inside a silence that is harder to break. It sits at the intersection of medical vulnerability and cultural expectation in a way that makes it, for many men, one of the most difficult diagnoses to receive, to process, and to discuss. A man whose sperm count is severely low, or whose sperm carry significant DNA damage, or who has no sperm at all in his ejaculate, is dealing not just with a medical reality but with the weight of everything that reproductive capacity means in the cultural context in which most Indian men live their lives.

The result is that male infertility — which is a factor in approximately half of all cases of infertility — is systematically underdiagnosed, undertreated, and underrepresented in the conversations and stories that circulate about fertility treatment. The focus falls on the woman. The tests run on the man are minimal. The assumption, sometimes implicit and sometimes explicit, is that if the semen analysis is roughly normal, the male factor has been adequately assessed.

It has not. And the stories in this article are the evidence for that.

These are stories of men whose infertility — real, specific, and in some cases apparently severe — was found, addressed, and overcome. Stories that demonstrate what is possible when male infertility is taken seriously, investigated thoroughly, and treated with the same depth of clinical attention that female infertility receives. Stories that doctors at volume-driven fertility clinics rarely share because they require acknowledging how often male factor infertility is missed — and how significantly that missing changes the outcome for the couple.

Why Male Infertility Is Systematically Underdiagnosed

Before the stories, the clinical context that makes them possible — and that makes understanding them important.

Male infertility is a factor in approximately 40 to 50 percent of all infertile couples — meaning that in nearly half of all cases where a couple cannot conceive, the male partner's fertility is contributing to the problem. In approximately 20 to 30 percent of infertile couples, male factor is the primary or sole cause of the difficulty.

Despite this prevalence, male infertility is routinely underdiagnosed in clinical practice — for a set of reasons that are structural, cultural, and clinical.

The limitations of standard semen analysis. The standard semen analysis measures three parameters — count, motility, and morphology — and produces a report that is interpreted against reference ranges established by the World Health Organization. A result within these ranges is described as normal. A result outside them is described as abnormal. The clinical problem is that this framework is both an imperfect measure of fertility — significant fertility can exist with below-range parameters, and significant infertility can exist with within-range parameters — and an incomplete assessment of male reproductive function.

The most significant gap in standard semen analysis is sperm DNA fragmentation — the integrity of the genetic material carried within sperm. As described extensively in previous articles in this series, high sperm DNA fragmentation can coexist with entirely normal count, motility, and morphology. It is invisible to standard analysis. And it is one of the most important determinants of whether IVF cycles succeed or fail — affecting embryo developmental competence, implantation rates, and miscarriage rates in ways that are directly attributable to the male partner's contribution but are attributed to unexplained failure because the right test was never ordered.

The cultural barrier to male evaluation. In many clinical encounters, the suggestion of a detailed male evaluation — beyond the standard semen analysis — is not made because the clinician anticipates resistance, or because the cultural norm in the clinical environment treats female investigation as primary and male evaluation as secondary. This cultural barrier is real, and it has clinical consequences: men are not fully investigated, contributing causes are missed, and cycles fail for reasons that the female partner is assumed to carry.

The surgical option that is not offered. In cases of azoospermia — zero sperm in the ejaculate — many couples are told, at their first and sometimes only consultation, that biological fatherhood is not possible. This conclusion is not always correct. In obstructive azoospermia — where sperm production is normal but a blockage prevents sperm from reaching the ejaculate — surgical sperm retrieval can obtain sperm directly from the testes. In non-obstructive azoospermia — where sperm production is impaired — a significant proportion of men have focal areas of active spermatogenesis within the testes that surgical retrieval can access. The couple told that biological fatherhood is impossible may be a couple who has never been referred to a specialist with the surgical expertise to determine whether sperm can be found — and whether what is found is sufficient for ICSI.

These three gaps — the limitations of standard analysis, the cultural barrier to full evaluation, and the surgical option not offered — define the space within which the stories in this article become possible.

Story One: Vikram and the Number Zero

Vikram was thirty-four when he and his wife Anita came to Metro IVF. They had been trying to conceive for four years. The single semen analysis that had been performed, two years earlier at a general hospital, had returned a result that the doctor had described to them in one word: azoospermia. No sperm. The doctor had told them, in the same brief consultation, that this meant biological fatherhood was not possible for Vikram, and that they should consider adoption or donor sperm.

They had sat with that conclusion for two years — not accepting it, but not knowing how to challenge it, because the authority with which it had been delivered had made it feel like a biological fact rather than a clinical opinion.

At Metro IVF, Dr. Soni reviewed Vikram's single previous semen analysis and conducted a fresh assessment. He ordered hormonal evaluation — FSH, LH, testosterone, and prolactin — and a scrotal ultrasound. He asked specifically about Vikram's history: any childhood illness, any groin surgery, any history of undescended testes, any significant fever, any current medications. The history revealed that Vikram had undergone an inguinal hernia repair at age nineteen — surgery that had not been mentioned to the previous doctor, because no one had asked.

The hormonal profile was within normal range. The scrotal ultrasound showed normal testicular volume bilaterally with no varicocele. The combination of a history of inguinal surgery with normal hormone levels and normal testicular volume suggested obstructive azoospermia — a blockage in the vas deferens or epididymis, likely related to the previous surgery, preventing sperm from reaching the ejaculate.

Dr. Soni explained the clinical picture to Vikram and Anita. He explained that obstructive azoospermia — if confirmed — meant that sperm production in the testes might be entirely normal. The problem was not with the sperm. It was with the plumbing. And a surgical procedure — testicular sperm aspiration, TESA — could obtain sperm directly from the testes, bypassing the obstruction, for use in ICSI.

Vikram underwent TESA under sedation. Sperm were found — motile, in adequate numbers for ICSI use. Anita underwent a standard IVF cycle. Two embryos were created. One was transferred. Anita conceived on the first attempt.

Vikram's son was born at term.

The doctor who had told Vikram that biological fatherhood was not possible had performed one semen analysis, asked no clinical history, and reached a final conclusion without surgical assessment. The doctor who made fatherhood possible performed a clinical history, a hormonal assessment, an ultrasound, a surgical procedure, and a referral pathway that connected diagnosis to treatment.

The difference between those two approaches is the difference between a couple who spent two years believing something that was not true and the couple who are now parents.

Story Two: Arjun and the Normal Report That Was Not the Whole Story

Arjun's semen analysis had been described as normal — normal count, normal motility, normal morphology — at two different clinics across three years of fertility treatment. His contribution to the investigation had, as a result, been considered complete. The focus of evaluation and treatment had fallen entirely on his wife Meena.

Meena had undergone two IVF cycles. Good embryos had been produced from both cycles — the embryologists at both clinics had described the blastocysts as grade A. Neither cycle had resulted in implantation. The explanation offered after each failure was the same: sometimes good embryos do not implant, the reasons are not always identifiable, let us try again.

At Metro IVF, Dr. Soni read both cycle reports and noted something that the previous clinics had not acted on: the embryos from both cycles had reached blastocyst stage but the blastocyst quality — while graded as A for the inner cell mass — showed a pattern of slightly irregular trophectoderm development that was consistent with, though not diagnostic of, sperm DNA fragmentation affecting embryo developmental competence at a cellular level beneath the morphological grading.

He ordered sperm DNA fragmentation testing for Arjun. The DFI was 34 percent — severely elevated. Two cycles of IVF had been conducted with sperm carrying DNA fragmentation at this level, and the embryos it had produced — however well they had looked under the microscope — had not had the developmental competence to implant.

The cause of Meena and Arjun's repeated IVF failure was, in the clinical picture that the DFI result completed, primarily the male factor. A factor that had been present throughout two cycles of treatment focused almost entirely on Meena.

Arjun underwent a scrotal ultrasound that identified a moderate bilateral varicocele — present but not identified at previous assessments because scrotal ultrasound had never been ordered. Microsurgical varicocelectomy was performed. A twelve-week antioxidant course followed. A repeat DFI at the end of the period showed reduction to 17 percent — within the range considered acceptable.

A third IVF cycle was performed — this time using ejaculated sperm from Arjun with a DFI that was no longer elevated, with ICSI to ensure optimal sperm selection, and with PGT-A on the resulting embryos to confirm chromosomal normality before transfer.

The third cycle produced three blastocysts. PGT-A confirmed two as euploid. The first euploid embryo transferred resulted in implantation. Meena delivered a healthy daughter at term.

The first two IVF cycles — and the two years of unexplained failure before them — had a specific explanation that was in Arjun's sperm all along. It was found, finally, when a doctor ordered the test that found it.

Story Three: Rajesh and the Diagnosis No One Had Named

Rajesh came to Metro IVF alone for his initial assessment — his wife Kavya was ill with a brief fever on the appointment day and could not travel. He came, he said, because she had asked him to — because after five years of infertility and one failed IVF cycle in which no one had paid serious attention to his contribution beyond the standard analysis, she had decided that his side of the investigation deserved the same thoroughness that hers had received.

Rajesh's semen analysis showed severe oligozoospermia — a sperm count of 1.2 million per milliliter, far below the WHO reference range of 16 million per milliliter. Previous doctors had documented this finding. Previous doctors had described it as a contributing factor. None had investigated why.

Dr. Soni's assessment of Rajesh began with the question that should begin every male infertility evaluation: what is causing this?

The hormonal profile showed elevated FSH — significantly above the normal range — with low testosterone and small testicular volume. This pattern — elevated FSH, low testosterone, small testes — is consistent with primary testicular failure: the testes are not producing sperm normally despite appropriate hormonal signaling from the pituitary, because the testicular tissue itself is impaired.

A karyotype — chromosomal analysis of a blood sample — was ordered. The result showed a 47,XXY karyotype: Klinefelter syndrome, a genetic condition in which a man has an extra X chromosome, resulting in primary testicular insufficiency and typically causing azoospermia or severe oligospermia.

Rajesh had Klinefelter syndrome. He was thirty-one. He had never been told. In five years of fertility investigations, including a failed IVF cycle, no one had ordered a karyotype. The cause of his severe sperm deficiency — present from birth, genetic in origin, and fundamentally relevant to how his case should be managed — had never been named.

Klinefelter syndrome does not mean biological fatherhood is impossible. In men with Klinefelter syndrome, small focal areas of active spermatogenesis may be present within the testes — areas that can be identified and accessed through a procedure called micro-TESE: microsurgical testicular sperm extraction, in which the testicular tissue is examined under a surgical microscope to identify and retrieve the small numbers of sperm that may be present in active spermatogenic foci.

Dr. Soni referred Rajesh for genetic counseling — to explain the diagnosis and its implications, to discuss the options and the uncertainties, and to ensure that the decision about micro-TESE was made with complete information and genuine informed consent.

Rajesh underwent micro-TESE. Sperm were found — small in number but motile and morphologically normal. Kavya underwent IVF stimulation. ICSI was performed using the retrieved testicular sperm. Two embryos were produced. One was transferred. Kavya's blood test fourteen days later was positive.

Their son was born at thirty-eight weeks. He has, by Rajesh's account, his father's eyes.

Rajesh asked us to include his story specifically because of the five years during which his diagnosis was unnamed — the years of treatment focused on the wrong questions, the failed IVF cycle conducted without the information that would have changed its management, and the couple who almost accepted that biological fatherhood was not possible before a karyotype revealed what had been present all along.

The Pattern Across These Stories

Three men. Three different diagnoses. Three different clinical presentations. And one clinical pattern that runs through all of them — through male infertility cases at Metro IVF more broadly — that is worth naming directly.

In every case, the investigation performed at previous clinics was insufficient. Not because the technology for a better investigation did not exist — it did. Not because the diagnosis was rare or exotic — azoospermia, sperm DNA fragmentation, and Klinefelter syndrome are all conditions that a fertility specialist should evaluate for in appropriate clinical presentations. But because the clinical culture in which these couples were treated did not prioritize male factor investigation, did not order the tests that would have found the answers, and did not connect the dots between the investigation findings and the clinical management.

The male factor was present in all three cases from the beginning. What changed was not the biology. What changed was the doctor — and the thoroughness of the investigation.

What a Complete Male Infertility Assessment Looks Like at Metro IVF

At Metro IVF, male infertility is never dismissed after a normal semen analysis — because Dr. Soni recognizes that a normal semen analysis is the beginning of the male evaluation, not the conclusion.

The complete male assessment at Metro IVF includes a clinical history — covering childhood illnesses, surgical history, medications, occupational and environmental exposures, and any previous fertility investigations. It includes a physical examination — scrotal palpation to assess testicular volume and the presence of varicocele. It includes a fresh semen analysis using strict morphological criteria, with sperm DNA fragmentation testing performed as a standard component — not an optional extra.

Where the hormonal profile is indicated — in cases of severe oligospermia or azoospermia — FSH, LH, testosterone, and prolactin are assessed. Scrotal Doppler ultrasound is performed to identify varicocele with greater sensitivity than clinical examination alone. Genetic testing — karyotype and Y chromosome microdeletion analysis — is recommended where the clinical picture suggests a genetic contributing factor. And where azoospermia is confirmed, the distinction between obstructive and non-obstructive causes is pursued through hormonal assessment, testicular volume measurement, and where indicated, surgical evaluation.

This assessment takes time. It requires clinical engagement with the male partner's history and biology that goes beyond what most fertility clinics apply. It requires the willingness to find something — even when finding something is more complicated than assuming the female partner carries the problem.

But it is the assessment that finds Vikram's obstructed vas deferens. It is the assessment that finds Arjun's varicocele-driven DNA fragmentation. It is the assessment that names Rajesh's Klinefelter syndrome.

And finding those things is what makes fatherhood possible for men who were told it was not.

A Word for Men Reading This

If you are a man who has been told your semen analysis is normal and the fertility investigation is focused on your partner — or if you have been told that a low sperm count or azoospermia means biological fatherhood is not possible — this article is written specifically for you.

Your semen analysis is not the complete picture of your fertility. Sperm DNA fragmentation is not assessed by standard analysis. Varicocele is not identified by laboratory testing. Hormonal and genetic factors that affect sperm production are not visible on a semen report. And the conclusion that biological fatherhood is impossible may have been reached before the assessment that would determine whether it is actually impossible was ever performed.

A detailed, thorough, honest male fertility assessment — of the kind that Dr. Soni performs at Metro IVF — is the only way to know what is actually possible for you. Not a semen analysis that was done two years ago at a general hospital. A current, complete, individually conducted evaluation that asks the right questions and performs the right tests.

That evaluation is available in Ambikapur. The stories in this article are the evidence of what it can reveal — and what it can make possible.

Your Next Step

If male infertility is a factor in your fertility journey — whether it has been thoroughly investigated or barely assessed — a consultation with Dr. Ashish Soni at Metro IVF in Ambikapur is the right starting point for understanding what is actually happening and what can be done about it.

The fertility treatment journey belongs to both partners equally. The investigation should too.

Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist

Male infertility is half the picture. Is your half of the investigation complete? Book your consultation with Dr. Soni at Metro IVF today — and find out what the right assessment reveals.